Treatment Of Early Stage Follicular Lymphoma With Involved Field Radiotherapy and Rituximab. Role Of Bcl-2 Molecular Monitoring

被引：0
|
作者：
Pulsoni, Alessandro
Della Starza, Irene
D'Urso, Pasqualina
Maria D'Elia, Gianna
Annechini, Giorgia
Stefanizzi, Caterina
De Angelis, Federico
Tricarico, Sara
Grapulin, Lavinia
Cavalli, Marzia
FoA, Robin
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.1813.1813
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1813
引用
收藏
页数：2
相关论文
共 50 条
  • [1] EARLY STAGE FOLLICULAR LYMPHOMA: ROLE OF MOLECULAR MONITORING IN PATIENTS TREATED WITH LOCAL RADIOTHERAPY ± RITUXIMAB
    Pulsoni, A.
    Della Starza, I.
    De Angelis, F.
    Annechini, G.
    D'Elia, G.
    Panfilio, S.
    Cavalli, M.
    Grapulin, L.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 : 185 - 185
  • [2] Radiotherapy with rituximab as first-line treatment for early-stage follicular lymphoma
    Cencini, Emanuele
    Fabbri, Alberto
    Schiattone, Luana
    Bartalucci, Giulia
    Bocchia, Monica
    [J]. LEUKEMIA & LYMPHOMA, 2015, 56 (10) : 2997 - 2998
  • [3] EARLY STAGE FOLLICULAR LYMPHOMA: BCL2/IGH ANALYSIS AT BASELINE AND FOR MINIMAL RESIDUAL DISEASE MONITORING CAN PREDICT RELAPSE AND DRIVE RITUXIMAB TREATMENT AFTER RADIOTHERAPY
    Cappelli, L. V.
    Pulsoni, A.
    Della Starza, I.
    Cavalli, M.
    De Novi, L. A.
    Tosti, M. E.
    Annechini, G.
    D'Elia, G. M.
    Grapulin, L.
    Guarini, A.
    Del Giudice, I.
    Foa, R.
    [J]. HAEMATOLOGICA, 2018, 103 : S59 - S60
  • [4] Minimal residual disease monitoring in early stage follicular lymphoma can predict prognosis and drive treatment with rituximab after radiotherapy
    Pulsoni, Alessandro
    Della Starza, Irene
    Cappelli, Luca V.
    Tosti, Maria E.
    Annechini, Giorgia
    Cavalli, Marzia
    De Novi, Lucia A.
    D'Elia, Gianna M.
    Grapulin, Lavinia
    Guarini, Anna
    Del Giudice, Ilaria
    Foa, Robin
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2020, 188 (02) : 249 - 258
  • [5] Outcome of involved-field radiotherapy for stage 1 follicular lymphoma
    Tomita, Naoto
    Kodama, Fumio
    Motohashi, Kenji
    Fujita, Atsuko
    Hyo, Rie
    Hashimoto, Chizuko
    Takemura, Sachiya
    Yamazaki, Etsuko
    Taguchi, Jun
    Sakai, Rika
    Fujisawa, Shin
    Kanamori, Helwa
    Motomura, Shigeki
    Ishigatsubo, Yoshiaki
    Takeuchi, Kengo
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2006, 83 (04) : 370 - 372
  • [6] Outcome of Involved-Field Radiotherapy for Stage 1 Follicular Lymphoma
    Naoto Tomita
    Fumio Kodama
    Kenji Motohashi
    Atsuko Fujita
    Rie Hyo
    Chizuko Hashimoto
    Sachiya Takemura
    Etsuko Yamazaki
    Jun Taguchi
    Rika Sakai
    Shin Fujisawa
    Heiwa Kanamori
    Shigeki Motomura
    Yoshiaki Ishigatsubo
    Kengo Takeuchi
    [J]. International Journal of Hematology, 2006, 83 : 370 - 372
  • [7] REDUCING THE RADIOTHERAPY FIELD SIZE IN THE CURATIVE TREATMENT OF LIMITED STAGE, FOLLICULAR LYMPHOMA: INVOLVED REGIONAL RADIOTHERAPY VERSES INVOLVED NODAL RADIOTHERAPY
    Campbell, B.
    Connors, J.
    Woods, R.
    Gascoyne, R.
    Morris, J.
    Pickles, T.
    Savage, K.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S20 - S20
  • [8] Treatment of limited stage follicular lymphoma with Rituximab immunotherapy and involved field radiotherapy in a prospective multicenter Phase II trial-MIR trial
    Witzens-Harig, Mathias
    Hensel, Manfred
    Unterhalt, Michael
    Herfarth, Klaus
    [J]. BMC CANCER, 2011, 11
  • [9] Treatment of limited stage follicular lymphoma with Rituximab immunotherapy and involved field radiotherapy in a prospective multicenter Phase II trial-MIR trial
    Mathias Witzens-Harig
    Manfred Hensel
    Michael Unterhalt
    Klaus Herfarth
    [J]. BMC Cancer, 11
  • [10] CHARACTERIZATION OF THE PROTEIN PRODUCT OF BCL-2, THE GENE INVOLVED IN HUMAN FOLLICULAR LYMPHOMA
    TSUJIMOTO, Y
    IKEGAKI, N
    CROCE, CM
    [J]. ONCOGENE, 1987, 2 (01) : 3 - 7
12345